Company OverviewVistaGen Therapeutics
VistaGen Therapeutics, Inc. (NASDAQ:VTGN) is a clinical-stage biopharmaceutical company committed to developing and commercializing new generation medications that go beyond the current standard of care for anxiety, depression and other central nervous system (CNS) disorders.
Speaker Bio Shawn K. Singh
CEO & Director
VistaGen Therapeutics
CEO & Director
VistaGen Therapeutics
Shawn Singh has has nearly 30 years of experience working with private and public biotechnology, medical device, and pharmaceutical companies, a venture capital firm, and a profitable contract research and development organization (CRO), serving in numerous senior management roles.
